Explore | Latest

2 investments found


Synartro develops improved treatments based on patented drug delivery technology and novel uses of drugs with proven safety and efficacy.
Funded SEK 16,977,996
Capital Target SEK 16,977,996
Max. Raise SEK 16,977,996
Min. Raise SEK 10,186,762
Percent of Equity Offered 61%
Valuation of equity SEK 28000000
End Date 26 October 2020
1 Startup Solna
View Investment


PharmNovo addresses the high unmet need of treatments for chronic pain
Funded SEK 21,667,764.80
Capital Target SEK 23,500,000
Max. Raise SEK 23,533,061.40
Min. Raise SEK 10,000,000
Percent of Equity Offered 63%
Valuation of equity SEK 37400000
End Date 03 October 2020
1 Startup Lund
View Investment